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Purpose:
Successful formation of amorphous solid dispersions (ASD) depends on a complex combination
of materials properties that facilitate prolonged interactions between API molecules and the
carrier polymer matrix. It is hypothesized that the atomic mass weighted 3rd-order
autocorrelation index (R3m molecular descriptor) is highly correlated with the combined
structural attributes of the API molecule that facilitate dispersion in polyvinyl pyrrolidone-vinyl
acetate co-polymer (PVPva). R3m has previously been used to predict ASD formation in PVPva
for a library of 15 API at two compositions (15% and 75% w/w), resulting in an overall accuracy
of 100% for predictions of dispersability when prepared by melt-quenching. Although successful
by this preparation method, it remains uncertain whether R3m predictions of dispersability can
be more broadly applied for the same API for different manufacturing routes. To examine this
question, ASD attempts were prepared at 75% w/w loading using rotary-evaporation and spraydrying and subsequent characterization used to confirm dispersion formation predictions for 6
API from the original library.
Methods:
Molecular structures were used to calculate R3m for each API using E-Dragon (vcclab.org). Six API
were selected: propranolol×HCl, nifedipine, sulfanilamide, ketoconazole, indomethacin, and
felodipine, 3 with R3m<0.65 and 3 with R3m>0.65, where R3m>0.65 corresponds to the
predictive boundary for dispersability in PVPva. Dry mixtures of 75% w/w API and PVPva were
prepared in a fixed ratio for all dispersion attempts, which were then dissolved in methanol. The
solvent was removed from the solutions using either rotary-evaporation (MeOH removal over
several minutes) or spray-drying (MeOH removal in seconds). All co-solidified mixtures were
characterized 24 hr after preparation. Dispersibility of each API in PVPva was inferred using a
suite of analytical techniques, which included differential scanning calorimetry (DSC), powder Xray diffraction (PXRD), polarized light microscopy (PLM), and hot stage microscopy (HSM) to
determine if a single homogeneous phase had been produced.
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Results:
Complete dispersability was inferred when samples had a single glass transition temperature (Tg)
by DSC, absence of birefringence under PLM at ambient temperature, and absence of Bragg
diffraction peaks attributable to the API via PXRD. Preparations of propranolol×HCl, nifedipine,
and sulfanilamide with PVPva showed Bragg diffraction peaks after melt-quenching and rotaryevaporation, although the same peaks were not detectable in PXRD patterns for the spray-dried
particles of these drugs. PLM studies showed birefringence, suggesting that the crystallinity in
spray-dried particles was below the detection limit of the PXRD instrument. DSC studies indicated
immiscibility of propranolol×HCl, nifedipine, and sulfanilamide with PVPva by the presence of
melting endotherms and/or multiple Tg events in the co-solidified mixtures regardless of
preparation method. In contrast, characterization of the ketoconazole, indomethacin, and
felodipine preparations showed no indications of phase separation from PVPva in co-solidified
mixtures prepared by any method. Table 1 summarizes all characterization data, indicating that
propranolol×HCl, nifedipine, and sulfanilamide are not dispersable in PVPva at 75% w/w
composition using any of the preparation methods, while ketoconazole, indomethacin, and
felodipine are. These data are also consistent with the previously established R3m model, in
which API having R3m>0.65 are dispersable in PVPva, while those with R3m<0.65 are not (Figure
1). Furthermore, observations of dispersability were consistent regardless of the rate of solvent
evaporation.
Conclusion:
Molecular structure determines the subtle aspects of API chemistry that lead to successful
dispersion formation in PVPva. Although the R3m model was originally developed for use with
specific preparation conditions, this work demonstrates that the predictive power of this
molecular descriptor remains applicable for the 6 API studied, when the production method
changes significantly. These data indicate the utility of the R3m model for dispersability
prediction as a formulation and process development tool for ASDs prepared using PVPva as a
carrier polymer.
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Table 1: Final characterization inferences based on interpretations of data from the suite of analytical techniques

Figure 1: Modeling of dichotomous classifications of API dispersability in PVPva for co-solidified mixtures prepared by (a) Meltquenching (yellow triangles), (b) Rotary-evaporation (blue squares), and (c) Spray-Drying (red diamonds) against the molecular
descriptor R3m. All API having R3m >0.65 were dispersible in PVPva by all three different manufacturing methods
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